{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:23:31Z","timestamp":1794626611182,"version":"4.9.1"},"reference-count":56,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012546","name":"Chongqing Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["CSTB2023NSCQ-BHX0044"],"award-info":[{"award-number":["CSTB2023NSCQ-BHX0044"]}],"id":[{"id":"10.13039\/100012546","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.atherosclerosis.2025.119216","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T18:25:27Z","timestamp":1745691927000},"page":"119216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Valine acts as an early biomarker and exacerbates pathological cardiac hypertrophy by impairing mitochondrial quality control"],"prefix":"10.1016","volume":"405","author":[{"given":"Hongyu","family":"Kuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmi","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaan","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehui","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2025.119216_bib1","first-page":"895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of Cardiology\/american heart association joint committed on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib3","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.hfc.2019.09.001","article-title":"Hypertension and heart failure: prevention, targets, and treatment","volume":"16","author":"Di Palo","year":"2020","journal-title":"Heart Fail Clin"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib4","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(07)61299-9","article-title":"Essential hypertension","volume":"370","author":"Messerli","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib5","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/CRD.0b013e318274956d","article-title":"Energy metabolism in cardiac remodeling and heart failure","volume":"21","author":"Azevedo","year":"2013","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s11897-023-00589-y","article-title":"Myocardial metabolism in heart failure","volume":"20","author":"Ng","year":"2023","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1161\/CIRCRESAHA.113.302095","article-title":"Cardiac metabolism and its interactions with contraction, growth, and survival of cardiomyocytes","volume":"113","author":"Kolwicz","year":"2013","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib8","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41569-022-00760-3","article-title":"Branched-chain amino acids in cardiovascular disease","volume":"20","author":"McGarrah","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib9","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1126\/science.aav0558","article-title":"Branched-chain amino acids in disease","volume":"363","author":"White","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.119.13735","article-title":"Concentration of branched-chain amino acids is a strong risk marker for incident hypertension","volume":"74","author":"Flores-Guerrero","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib11","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.032084","article-title":"Causal relationship between branched-chain amino acids and hypertension: a mendelian randomization study","volume":"13","author":"Cai","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17047-0","article-title":"Dietary amino acids and incidence of hypertension: a principle component analysis approach","volume":"7","author":"Teymoori","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib13","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/1753-0407.12645","article-title":"Diabetes and branched chain amino acids: what is the link?","volume":"10","author":"Bloomgarden","year":"2018","journal-title":"J Diabetes"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib14","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1161\/CIRCULATIONAHA.115.020226","article-title":"Catabolic defect of branched-chain amino acids promotes heart failure","volume":"133","author":"Sun","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/cvr\/cvr070","article-title":"Branched-chain amino acid metabolism in heart disease: an epiphenomenon or a real culprit?","volume":"90","author":"Huang","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib16","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s12933-019-0892-3","article-title":"Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure","volume":"18","author":"Uddin","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib17","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1161\/CIRCHEARTFAILURE.114.001469","article-title":"Energy metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach","volume":"7","author":"Lai","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib18","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/CIRCHEARTFAILURE.114.001151","article-title":"Metabolomic analysis of pressure-overloaded and infarcted mouse hearts","volume":"7","author":"Sansbury","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010926","article-title":"Metabolic changes in spontaneously hypertensive rat hearts precede cardiac dysfunction and left ventricular hypertrophy","volume":"8","author":"Li","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib20","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.cmet.2021.03.025","article-title":"The adverse metabolic effects of branched-chain amino acids are mediated by isoleucine and valine","volume":"33","author":"Yu","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.atherosclerosis.2022.04.026","article-title":"Association of circulating branched-chain amino acids with risk of cardiovascular disease: a systematic review and meta-analysis","volume":"350","author":"Wang","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib22","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1161\/CIRCULATIONAHA.121.055727","article-title":"DYRK1B-STAT3 drives cardiac hypertrophy and heart failure by impairing mitochondrial bioenergetics","volume":"145","author":"Zhuang","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.625020","article-title":"mtDNA heteroplasmy at the core of aging-associated heart failure. An integrative view of OXPHOS and mitochondrial life cycle in cardiac mitochondrial physiology","volume":"9","author":"Elorza","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib24","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011625","article-title":"Therapeutic effect of targeting branched-chain amino acid catabolic flux in pressure-overload induced heart failure","volume":"8","author":"Chen","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102696","article-title":"Elevated branched-chain amino acid promotes atherosclerosis progression by enhancing mitochondrial-to-nuclear H2O2-disulfide HMGB1 in macrophages","volume":"62","author":"Zhao","year":"2023","journal-title":"Redox Biol"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.121.009521","article-title":"Defects in the proteome and metabolome in human hypertrophic cardiomyopathy","volume":"15","author":"Previs","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib27","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1161\/HYPERTENSIONAHA.109.138818","article-title":"Mammalian target of rapamycin is a critical regulator of cardiac hypertrophy in spontaneously hypertensive rats","volume":"54","author":"Soesanto","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib28","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1097\/HJH.0000000000003480","volume":"41","author":"Mancia","year":"2023","journal-title":"J Hypertens"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172796","article-title":"PP2Cm overexpression alleviates MI\/R injury mediated by a BCAA catabolism defect and oxidative stress in diabetic mice","volume":"866","author":"Lian","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib30","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1152\/ajpheart.00114.2016","article-title":"Defective branched chain amino acid catabolism contributes to cardiac dysfunction and remodeling following myocardial infarction","volume":"311","author":"Wang","year":"2016","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib31","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1139\/cjpp-2014-0060","article-title":"Dysregulation of Mfn2 and Drp-1 proteins in heart failure","volume":"92","author":"Givvimani","year":"2014","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib32","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/d41573-021-00107-6","article-title":"BCKDK: an emerging kinase target for metabolic diseases and cancer","volume":"20","author":"East","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/SHK.0000000000001040","article-title":"Blocking liver autophagy accelerates apoptosis and mitochondrial injury in hepatocytes and reduces time to mortality in a murine sepsis model","volume":"50","author":"Oami","year":"2018","journal-title":"Shock"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib34","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1152\/physrev.00006.2004","article-title":"Myocardial substrate metabolism in the normal and failing heart","volume":"85","author":"Stanley","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib35","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/cvr\/cvn301","article-title":"Energy metabolism in heart failure and remodelling","volume":"81","author":"Ingwall","year":"2009","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib36","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1093\/cvr\/cvad100","article-title":"Cardiac lipid metabolism, mitochondrial function, and heart failure","volume":"119","author":"Da","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib37","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0735-1097(02)01967-8","article-title":"Altered myocardial fatty acid and glucose metabolism in idiopathic dilated cardiomyopathy","volume":"40","author":"D\u00e1vila-Rom\u00e1n","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib38","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s10741-012-9359-2","article-title":"Cardiac metabolism in hypertrophy and heart failure: implications for therapy","volume":"18","author":"Siddiqi","year":"2013","journal-title":"Heart Fail Rev"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2025.119216_bib39","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1038\/s41467-021-21962-2","article-title":"Branched-chain \u03b1-ketoacids are preferentially reaminated and activate protein synthesis in the heart","volume":"12","author":"Walejko","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib40","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1161\/CIRCULATIONAHA.122.061846","article-title":"Myocardial metabolomics of human heart failure with preserved ejection fraction","volume":"147","author":"Hahn","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib41","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1161\/CIRCULATIONAHA.121.053575","article-title":"Altered cardiac energetics and mitochondrial dysfunction in hypertrophic cardiomyopathy","volume":"144","author":"Ranjbarvaziri","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib42","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1161\/CIRCRESAHA.117.311082","article-title":"Autophagy and mitophagy in cardiovascular disease","volume":"120","author":"Bravo-San","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib43","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s12265-010-9189-3","article-title":"Autophagy induced by ischemic preconditioning is essential for cardioprotection","volume":"3","author":"Huang","year":"2010","journal-title":"J Cardiovasc Transl Res"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib44","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1007\/s10741-018-9708-x","article-title":"Anti-apoptosis in nonmyocytes and pro-autophagy in cardio-myocytes: two strategies against postinfarction heart failure through regulation of cell death-degeneration","volume":"23","author":"Takemura","year":"2018","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib45","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/cvr\/cvr073","article-title":"The role of autophagy emerging in postinfarction cardiac remodelling","volume":"91","author":"Kanamori","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib46","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/BF02932962","article-title":"Cardiac hypertrophy in rats after supravalvular aortic constriction inhibition of cellular autophagy in hypertrophying cardiomyocytes","volume":"43","author":"Dammrich","year":"1983","journal-title":"Virchows Arch B Cell Pathol Incl Mol Pathol"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib47","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1080\/15548627.2021.2020979","article-title":"Restoration of mitophagy ameliorates cardiomyopathy in Barth syndrome","volume":"18","author":"Zhang","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib48","first-page":"195","article-title":"Rapamycin regulates the balance between cardiomyocyte apoptosis and autophagy in chronic heart failure by inhibiting mTOR signaling","volume":"45","author":"Gao","year":"2020","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib49","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/CIRCRESAHA.117.311147","article-title":"New insights into the role of mTOR signaling in the cardiovascular system","volume":"122","author":"Sciarretta","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib50","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.cmet.2018.12.020","article-title":"Loss of BCAA catabolism during carcinogenesis enhances mTORC1 activity and promotes tumor development and progression","volume":"29","author":"Ericksen","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib51","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.molcel.2023.11.038","article-title":"A mitophagy sensor PPTC7 controls BNIP3 and NIX degradation to regulate mitochondrial mass","volume":"84","author":"Sun","year":"2024","journal-title":"Mol Cell"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106038","article-title":"Mitochondrial dysfunction and mitochondrial therapies in heart failure","volume":"175","author":"Wu","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib53","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/CIRCRESAHA.124.323800","article-title":"Mitochondrial structure and function in human heart failure","volume":"135","author":"Hinton","year":"2024","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib54","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.115.020502","article-title":"Drp1-dependent mitochondrial autophagy plays a protective role against pressure overload-induced mitochondrial dysfunction and heart failure","volume":"133","author":"Shirakabe","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib55","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2021108587","article-title":"DRP1 interacts directly with BAX to induce its activation and apoptosis","volume":"41","author":"Jenner","year":"2022","journal-title":"EMBO J"},{"key":"10.1016\/j.atherosclerosis.2025.119216_bib56","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1074\/mcp.M113.027649","article-title":"Quantitative phosphoproteomic study of pressure-overloaded mouse heart reveals dynamin-related protein 1 as a modulator of cardiac hypertrophy","volume":"12","author":"Chang","year":"2013","journal-title":"Mol Cell Proteomics"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025001145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915025001145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T16:28:47Z","timestamp":1762187327000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915025001145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":56,"alternative-id":["S0021915025001145"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.119216","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valine acts as an early biomarker and exacerbates pathological cardiac hypertrophy by impairing mitochondrial quality control","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2025.119216","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"119216"}}